Competing drugs to treat opioid addiction equally safe, according to study

In a randomised controlled trial in the US, extended-release naltrexone, also known as Vivitrol, and sublingual buprenorphine-naloxone, also known as Suboxone, were both found to be safe and effective.

Two of the main medicines used for treating opioid addiction are equally safe and effective, according to a new, multi-centre study in The Lancet.[1]

The federally funded, 24-week randomised controlled trial involved 570 patients addicted to opioids at eight US community-based inpatient facilities.

In a randomised controlled trial in the US, extended-release naltrexone, also known as Vivitrol, and sublingual buprenorphine-naloxone, also known as Suboxone, were both found to be safe and effective.

Two of the main medicines used for treating opioid addiction are equally safe and effective, according to a new, multi-centre study in The Lancet.[1]

The federally funded, 24-week randomised controlled trial involved 570 patients addicted to opioids at eight US community-based inpatient facilities.